Cathepsin B: association with plasma membrane in metastatic tumors
- PMID: 3458210
- PMCID: PMC323322
- DOI: 10.1073/pnas.83.8.2483
Cathepsin B: association with plasma membrane in metastatic tumors
Abstract
The subcellular localization of cathepsin B activity (EC 3.4.22.1) in three murine melanomas of increasing metastatic potential (Cloudman less than B16-F1 less than B16 amelanotic) was determined. Cathepsin B activity was localized in the heavy mitochondrial fraction of normal murine liver but in the light mitochondrial fraction of the metastatic melanomas; the localization of three other lysosomal hydrolases did not shift. Further purification of the light mitochondrial fraction into L-1 (density = 1.045 g/ml) and L-2 (density = 1.07 g/ml) fractions was achieved on a 30% iso-osmotic Percoll gradient. The L-1 fraction of liver and melanomas contained Na+, K+-ATPase activity; the L-2 fraction of liver contained four lysosomal hydrolase (cathepsins B and H, N-acetyl-beta-glucosaminidase, and beta-glucuronidase) and glucose-6-phosphatase activities. Ultrastructural examination revealed that the L-1 fraction consisted of membrane vesicles and the L-2 fraction of secondary lysosomes. In the B16 melanomas cathepsin B and N-acetyl-beta-glucosaminidase activities were found in both L-1 and L-2 fractions. Specific activities of the two enzymes in the plasma membrane (L-1) fractions increased in correspondence with metastatic potential. Cathepsin H and beta-glucuronidase activities were not localized in the plasma membrane fractions of the B16 melanomas. Localization of hydrolytic enzymes in the plasma membrane of metastatic tumor cells could result in focal dissolution of the extracellular matrix and thereby invasion and metastasis.
Similar articles
-
Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.Cancer Res. 1987 Dec 15;47(24 Pt 1):6620-8. Cancer Res. 1987. PMID: 2824039
-
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.Cancer Res. 1982 Mar;42(3):980-6. Cancer Res. 1982. PMID: 7059993
-
Lysosomal cathepsin B: correlation with metastatic potential.Science. 1981 Jun 5;212(4499):1151-3. doi: 10.1126/science.7233209. Science. 1981. PMID: 7233209
-
Plasma membrane-associated cysteine proteinases in human and animal tumors.Exp Cell Biol. 1987;55(4):209-24. doi: 10.1159/000163420. Exp Cell Biol. 1987. PMID: 3315769 Review.
-
Molecular regulation, membrane association and secretion of tumor cathepsin B.APMIS. 1999 Jan;107(1):28-37. doi: 10.1111/j.1699-0463.1999.tb01523.x. APMIS. 1999. PMID: 10190277 Review.
Cited by
-
Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.Development. 1991 Jun;112(2):439-49. doi: 10.1242/dev.112.2.439. Development. 1991. PMID: 1794314 Free PMC article.
-
Variant cathepsin B activity secreted from human pancreatic cancer cell lines into protein-free chemically defined medium.Gastroenterol Jpn. 1989 Dec;24(6):699-706. doi: 10.1007/BF02774170. Gastroenterol Jpn. 1989. PMID: 2606304
-
A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells.Proc Natl Acad Sci U S A. 1990 Nov;87(21):8296-300. doi: 10.1073/pnas.87.21.8296. Proc Natl Acad Sci U S A. 1990. PMID: 2172980 Free PMC article.
-
Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases.Am J Pathol. 2001 Aug;159(2):449-55. doi: 10.1016/S0002-9440(10)61716-6. Am J Pathol. 2001. PMID: 11485903 Free PMC article.
-
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.Cell Mol Life Sci. 2010 Dec;67(23):3947-60. doi: 10.1007/s00018-010-0469-5. Epub 2010 Aug 5. Cell Mol Life Sci. 2010. PMID: 20686912 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials